Having trouble accessing articles? Reset your cache.

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

Three women were appointed this week to C-suite positions at biotechs with valuations over $1 billion. The hires come the same week as a report from BIO that found that about 30% of biotech executives are female (see

Read the full 387 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE